Skip to main content

and
  1. Article

    Open Access

    Storm of Cardiovascular Markers After LPS Administration in Human Volunteers

    Acute infections are associated with an elevated cardiovascular risk. However, little is known about the interactions of acute inflammatory responses and the cardiovascular system. We therefore aimed to evalua...

    Michael Resl, Matthias Wolfgang Heinzl in Journal of Cardiovascular Translational Re… (2021)

  2. Article

    Open Access

    Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial

    Administration of lipopolysaccharide (LPS) from Gram-negative bacteria, also known as the human endotoxemia model, is a standardized and safe model of human inflammation. Experimental studies have revealed tha...

    Vincent Millischer, Matthias Heinzl, Anthi Faka in Journal of Neuroinflammation (2021)

  3. Article

    Open Access

    Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus

    Recently, the European Society of Cardiology (ESC) and European Association for the Society of Diabetes (EASD) introduced a new cardiovascular disease (CVD) risk stratification model to aid further treatment d...

    Suriya Prausmüller, Michael Resl, Henrike Arfsten in Cardiovascular Diabetology (2021)

  4. Article

    Correction to: Intrahospital mortality of influenza patients during the 2017–2018 influenza season

    Correction to:

    Florian Obendorf, Carmen Klammer, Matthias Heinzl in Wiener klinische Wochenschrift (2020)

  5. No Access

    Article

    Intrahospital mortality of influenza patients during the 2017–2018 influenza season

    Seasonal influenza is responsible for excess mortality and morbidity all over the northern hemisphere. To the authors’ knowledge there are no comprehensive data available about morbidity and mortality of hospi...

    Florian Obendorf, Carmen Klammer, Matthias Heinzl in Wiener klinische Wochenschrift (2020)

  6. Article

    Open Access

    Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

    Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the cla...

    Guntram Schernthaner, Chaim Lotan in Cardiovascular Diabetology (2018)

  7. No Access

    Article

    Estimated glomerular filtration rate and albuminuria: true predictors of cardiovascular events in obese patients with type 2 diabetes?

    Rezente Daten zeigen, dass die, mit der MDRD-Formel errechnete, glomeruläre Filtrationsrate (eGFR) bei adipösen Patienten falsch niedrig ist. In dieser Studie wurde daher evaluiert, ob dieser Berechnungsfehler...

    Michael Resl, Greisa Vila, Roland Kraxner, Richard Pacher in Wiener klinische Wochenschrift (2013)

  8. No Access

    Article

    Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss

    Recently, vaspin was identified as a novel adipokine with insulin-sensitizing effects that might be implicated in endogenous glucose regulation. Our objective was to evaluate the impact of acute weight loss an...

    Ammon Handisurya, Michaela Riedl, Greisa Vila, Christina Maier in Obesity Surgery (2010)